Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer

Cancer stem cells (CSCs) are expanded in anaplastic thyroid cancer (ATC) and standard treatment approaches have failed to improve survival, suggesting a need to specifically target the CSC population. Recent studies in breast and colorectal cancer demonstrated that inhibition of the SUMO pathway rep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: De Andrade, James P., Lorenzen, Allison W., Wu, Vincent T., Bogachek, Maria V., Park, Jung M., Gu, Vivian W., Sevenich, Claire M., Cassady, Victoria C., Beck, Anna C., Kulak, Mikhail V., Robinson, Robert A., Lal, Geeta, Weigel, Ronald J.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777733/
https://ncbi.nlm.nih.gov/pubmed/29383121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21954
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados